跳至主要内容
临床试验/IRCT20230307057646N1
IRCT20230307057646N1尚未招募3 期

Comparing the outcomes of 1% pimecrolimus cream with 0.1% mometasone cream in treatment of childhood vitiligo in the face, neck and trunk

Esfahan University of Medical Sciences0 个研究点目标入组 62 人开始时间: 待定最近更新:

试验速览

阶段
3 期
状态
尚未招募
入组人数
62

研究概览

简要总结

暂无简介。

研究设计

研究类型
Interventional

入排标准

年龄范围
no limit 至 18 years(—)
性别
All

入选标准

  • Vitiligo in less than 10 percent of body surface
  • non-segmental vitiligo
  • no history of allergic reaction to used drugs

排除标准

  • pregnancy and lactating
  • using other treatments for vitiligo lesions in last 6 months
  • severe allergic reactions to used drugs

研究者

相似试验

Comparing the outcomes pimecrolimus and mometasone... | 临床试验